Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation

Apr 3, 2024 | Brands, Company Investment, Manufacturing and Processing, News, Partnerships and Collaborations

Branded Legacy Strengthens Relationship with Surge Distribution Company, bolstering quarter 1 revenue

Melbourne, FL – 4/2/2024 – Branded Legacy, Inc. (OTC.PK: BLEG), a leading provider of innovative wellness products, proudly announces a significant white label agreement between its subsidiary Royal Biotek and Kava & Hobbs, LLC. This collaboration signifies a milestone in the burgeoning market for wellness-oriented vaping products.

Under the terms of the agreement, Branded Legacy will supply Kava & Hobbs with 6,000 units of their groundbreaking Kava Vapes per order, valued at just under $50,000. These state-of-the-art vaping products feature a unique formulation comprising CBD and terpene blends, paired with proprietary high-purity kava extract, distinguishing them as an unparalleled offering in the market.

Royal Biotek’s expertise in product development and branding has led to the creation of two distinct products for Kava & Hobbs: Sleepy Tiki and Zen Tiki. Crafted to promote relaxation and support restful sleep, these vapes embody tranquility and balance, offering consumers an unmatched vaping experience that fosters wellness and mindfulness.

“We are excited to partner with Kava & Hobbs, expanding the reach of our innovative Kava Vapes,” said David Oswald, CEO of Branded Legacy, Inc. “This white label deal reflects our commitment to delivering high-quality, effective products that cater to the evolving needs of consumers seeking holistic wellness solutions.”

Kava & Hobbs, LLC, shares Branded Legacy’s vision for wellness-centric products that prioritize natural ingredients and consumer well-being. The partnership underscores both companies’ dedication to excellence and innovation in the rapidly expanding market for both CBD and Kava-based products.

Branded Legacy also announced the signing of two more white label agreements with Surge Distribution Company. These new deals, with a combined value totaling approximately $50,000 per order, increases revenue from quarter one by over $100,000. “Branded Legacy is experiencing exponential revenue growth, demonstrating the success of our strategic partnerships and commitment to innovation,” stated Oswald.

Looking ahead to quarter two, Branded Legacy is already actively negotiating four additional white label deals and a large extraction contract, positioning the company for continued success and expansion in the rapidly growing wellness market.

In Other Company News, Branded Legacy recently announced the strategic acquisition of Sycamore BioPharma, Inc., a renowned developer of plant-based pharmaceuticals. This milestone solidifies Branded Legacy’s position in the biotech sector, securing assets exceeding $2 million and key personnel crucial for advancing clinical trials. The acquisition not only expands Branded Legacy’s portfolio with over $500,000 in inventory but also fosters synergies to drive sales growth and consumer outreach. Additionally, the collaboration welcomes Dr. Mark Hamann, a PHD holding scientist, to Branded Legacy’s team, enhancing efforts in pharmaceutical development and FDA approval processes.

For more information about Sycamore BioPharma, Inc, please visit Sycamore BioPharma

 

Investor Relations & Media Contact:

Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com

Download this Press Release

 

Safe Harbor Statement on Forward-Looking Language: This release includes forward-looking statements, which are based on certain assumptions and reflect management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “intends,” “goal,” “objective,” “seek,” “attempt,” or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.